AEON vs AMGN · P/E 0.0, $8.6M cap vs P/E 24, rev $10.05B
AEON Biopharma, Inc. (AEON) versus Amgen Inc (AMGN) — a side-by-side from cached financials, not a winner call.
AEON Biopharma, Inc. (AEON) is a biotechnology company listed on US.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
AEON does not have a complete income-statement cache yet.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
AEON currently screens at market cap $8.6M and trailing P/E 0.0. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Not investment advice. Open the AEON and AMGN stock pages for the full models.
Not investment advice.